In primary mediastinal large B-cell lymphoma, central nervous system (CNS) relapse is an uncommon event with a dismal prognosis. We report about the successful management of CNS relapse with chemoimmunotherapy according to MATRix (methotrexate, cytarabine, thiotepa, and rituximab) protocol followed by autologous stem cell transplant.
Keywords: MATRix regimen; autologous stem cell transplant; central nervous system involvement; primary mediastinal large B‐cell lymphoma.
© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.